StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a report published on Sunday morning. The firm issued a sell rating on the stock.
Separately, HC Wainwright lifted their price objective on shares of SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a report on Thursday, December 12th.
Get Our Latest Analysis on SNES
SenesTech Price Performance
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
See Also
- Five stocks we like better than SenesTech
- 3 Small Caps With Big Return Potential
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- 3 Stocks to Consider Buying in October
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- Top Stocks Investing in 5G Technology
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.